Research.Patient.info

autoimmune disorders research hub

1 indexed studies · 0 currently recruiting

authorisedTherapeutic use (Phase IV)
Biomarker-guided treatment-and-stop-strategy for recombinant IL-1receptor antagonist (anakinra) in patients with systemic Juvenile Idiopathic Arthritis
This study looks at how many injections of a medicine called anakinra (Kineret) children with systemic JIA need to stop their disease symptoms. It also checks if they stay well after stopping the medicine.
Netherlands